SurgePays Inc. Announces ATM Agreement with Titan Partners for $15 Million Common Stock Offering

Reuters
Aug 06
SurgePays Inc. Announces ATM Agreement with Titan Partners for $15 Million Common Stock Offering

SurgePays, Inc., a Nevada-based corporation, has entered into an At The Market Offering Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC. This agreement, dated August 5, 2025, allows SurgePays to offer and sell shares of its common stock through Titan as sales agent and/or principal. The sales will be conducted as an "at the market" offering under the Securities Act of 1933. The proceeds from this offering are intended to support the expansion of SurgePays' Lifeline business, as well as to provide additional working capital and cover general corporate expenses. The agreement permits the sale of common stock with an aggregate offering price of up to $15 million, adhering to the company's "baby shelf" limitations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgepays Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-022288), on August 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10